| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 33 | 2020 | 187 | 8.290 |
Why?
|
| Amygdala | 22 | 2020 | 61 | 5.980 |
Why?
|
| Alcohol Drinking | 14 | 2018 | 249 | 3.770 |
Why?
|
| Central Nervous System Depressants | 13 | 2017 | 63 | 2.850 |
Why?
|
| Glutamic Acid | 8 | 2020 | 47 | 2.820 |
Why?
|
| Synapses | 9 | 2020 | 83 | 2.530 |
Why?
|
| Synaptic Transmission | 11 | 2020 | 117 | 2.310 |
Why?
|
| Substance Withdrawal Syndrome | 9 | 2017 | 59 | 2.250 |
Why?
|
| Alcoholism | 11 | 2020 | 101 | 1.980 |
Why?
|
| Animals | 59 | 2020 | 7541 | 1.600 |
Why?
|
| Rats | 34 | 2020 | 1595 | 1.570 |
Why?
|
| Anxiety | 12 | 2017 | 191 | 1.510 |
Why?
|
| Receptors, GABA-A | 9 | 2011 | 32 | 1.360 |
Why?
|
| Neurons | 15 | 2013 | 410 | 1.360 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2020 | 743 | 1.260 |
Why?
|
| Excitatory Postsynaptic Potentials | 8 | 2020 | 32 | 1.140 |
Why?
|
| Receptors, Glycine | 5 | 2007 | 8 | 1.120 |
Why?
|
| Sex Characteristics | 2 | 2017 | 173 | 1.030 |
Why?
|
| Sodium Glutamate | 3 | 2015 | 3 | 0.960 |
Why?
|
| Strychnine | 4 | 2007 | 4 | 0.930 |
Why?
|
| Male | 42 | 2020 | 19165 | 0.880 |
Why?
|
| Conditioning, Operant | 3 | 2015 | 88 | 0.810 |
Why?
|
| Social Isolation | 5 | 2018 | 45 | 0.810 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2011 | 75 | 0.780 |
Why?
|
| Neuronal Plasticity | 4 | 2010 | 80 | 0.770 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2013 | 36 | 0.740 |
Why?
|
| Self Administration | 9 | 2018 | 297 | 0.720 |
Why?
|
| Patch-Clamp Techniques | 13 | 2013 | 75 | 0.720 |
Why?
|
| Mice, Inbred DBA | 6 | 2017 | 40 | 0.680 |
Why?
|
| Nerve Tissue Proteins | 4 | 2016 | 120 | 0.680 |
Why?
|
| Species Specificity | 6 | 2017 | 90 | 0.680 |
Why?
|
| Receptors, Kainic Acid | 2 | 2009 | 8 | 0.650 |
Why?
|
| SNARE Proteins | 1 | 2018 | 4 | 0.640 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2015 | 56 | 0.630 |
Why?
|
| Calcium Channels | 5 | 2001 | 57 | 0.620 |
Why?
|
| Nucleus Accumbens | 6 | 2018 | 94 | 0.610 |
Why?
|
| Drinking | 2 | 2015 | 10 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 8 | 2017 | 767 | 0.600 |
Why?
|
| Receptors, Metabotropic Glutamate | 5 | 1998 | 24 | 0.590 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2017 | 2 | 0.580 |
Why?
|
| RNA, Messenger | 11 | 2017 | 508 | 0.580 |
Why?
|
| Exocytosis | 1 | 2017 | 10 | 0.580 |
Why?
|
| Synaptic Vesicles | 1 | 2017 | 8 | 0.570 |
Why?
|
| Presynaptic Terminals | 2 | 2018 | 37 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 73 | 0.550 |
Why?
|
| Mice | 11 | 2017 | 2484 | 0.530 |
Why?
|
| Rats, Long-Evans | 8 | 2018 | 72 | 0.530 |
Why?
|
| Taurine | 3 | 2007 | 6 | 0.530 |
Why?
|
| Brain | 3 | 2020 | 951 | 0.520 |
Why?
|
| Drinking Behavior | 1 | 2015 | 10 | 0.510 |
Why?
|
| Dopamine | 5 | 2018 | 232 | 0.510 |
Why?
|
| Water | 1 | 2015 | 56 | 0.500 |
Why?
|
| Receptors, AMPA | 2 | 2012 | 13 | 0.490 |
Why?
|
| Receptors, Glutamate | 2 | 2012 | 6 | 0.490 |
Why?
|
| Organ Culture Techniques | 4 | 2017 | 39 | 0.480 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 633 | 0.460 |
Why?
|
| Thalamus | 1 | 2012 | 33 | 0.410 |
Why?
|
| Piperidines | 4 | 2015 | 118 | 0.410 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 495 | 0.400 |
Why?
|
| Ion Channel Gating | 3 | 2003 | 20 | 0.400 |
Why?
|
| Maze Learning | 3 | 2017 | 13 | 0.380 |
Why?
|
| Electrophysiology | 6 | 2009 | 70 | 0.370 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2011 | 33 | 0.370 |
Why?
|
| Administration, Inhalation | 4 | 2017 | 54 | 0.370 |
Why?
|
| Electric Stimulation | 5 | 2017 | 104 | 0.350 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2006 | 263 | 0.350 |
Why?
|
| Time Factors | 6 | 2018 | 2149 | 0.340 |
Why?
|
| GTP-Binding Proteins | 3 | 2017 | 23 | 0.340 |
Why?
|
| Chloride Channels | 3 | 2007 | 5 | 0.340 |
Why?
|
| Appetite | 1 | 2008 | 22 | 0.320 |
Why?
|
| Behavior, Animal | 4 | 2016 | 250 | 0.300 |
Why?
|
| Glutamates | 1 | 2007 | 11 | 0.300 |
Why?
|
| Choice Behavior | 3 | 2015 | 87 | 0.280 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 11 | 0.280 |
Why?
|
| Analysis of Variance | 4 | 2015 | 463 | 0.280 |
Why?
|
| Membrane Potentials | 6 | 2006 | 81 | 0.270 |
Why?
|
| Pyrazoles | 2 | 2015 | 67 | 0.250 |
Why?
|
| Norepinephrine | 2 | 2015 | 77 | 0.240 |
Why?
|
| Microinjections | 3 | 2011 | 35 | 0.240 |
Why?
|
| Glycine Agents | 1 | 2003 | 1 | 0.220 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 1022 | 0.220 |
Why?
|
| Signal Transduction | 5 | 2017 | 682 | 0.210 |
Why?
|
| Stress, Psychological | 2 | 2018 | 221 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2008 | 25 | 0.210 |
Why?
|
| Sucrose | 2 | 2013 | 18 | 0.210 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 7 | 0.190 |
Why?
|
| Cholinergic Agents | 1 | 2020 | 8 | 0.190 |
Why?
|
| Transketolase | 5 | 1995 | 5 | 0.190 |
Why?
|
| Superior Cervical Ganglion | 2 | 1998 | 3 | 0.190 |
Why?
|
| Glycine | 4 | 2004 | 27 | 0.190 |
Why?
|
| Female | 9 | 2018 | 19959 | 0.180 |
Why?
|
| RNA | 3 | 2006 | 92 | 0.180 |
Why?
|
| Phenotype | 2 | 2016 | 632 | 0.180 |
Why?
|
| Kidney | 3 | 2004 | 518 | 0.180 |
Why?
|
| RGS Proteins | 2 | 2017 | 18 | 0.170 |
Why?
|
| Drug Interactions | 2 | 2011 | 78 | 0.170 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2019 | 4 | 0.170 |
Why?
|
| Endocytosis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Ubiquitination | 1 | 2019 | 16 | 0.170 |
Why?
|
| Motor Activity | 2 | 2015 | 325 | 0.170 |
Why?
|
| Exploratory Behavior | 2 | 2011 | 30 | 0.160 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Macaca fascicularis | 5 | 2007 | 434 | 0.160 |
Why?
|
| Wernicke Encephalopathy | 4 | 1995 | 4 | 0.160 |
Why?
|
| Calcium Channels, N-Type | 1 | 1998 | 3 | 0.150 |
Why?
|
| Internal Capsule | 1 | 2017 | 1 | 0.150 |
Why?
|
| Estrous Cycle | 1 | 2017 | 3 | 0.150 |
Why?
|
| Random Allocation | 4 | 2015 | 226 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 40 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2017 | 7 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2016 | 79 | 0.150 |
Why?
|
| Calcium Channel Blockers | 2 | 1996 | 48 | 0.150 |
Why?
|
| Prefrontal Cortex | 3 | 2019 | 71 | 0.140 |
Why?
|
| Macaca mulatta | 1 | 2018 | 305 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 167 | 0.140 |
Why?
|
| Cell Line | 4 | 2004 | 435 | 0.140 |
Why?
|
| Humans | 14 | 2020 | 32005 | 0.140 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2016 | 8 | 0.140 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2016 | 24 | 0.130 |
Why?
|
| Peptides | 1 | 1996 | 120 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2007 | 109 | 0.130 |
Why?
|
| Virulence Factors, Bordetella | 4 | 2001 | 9 | 0.130 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 7 | 0.130 |
Why?
|
| Serotonin | 1 | 1995 | 37 | 0.130 |
Why?
|
| Reinforcement Schedule | 1 | 2015 | 57 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 62 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 276 | 0.120 |
Why?
|
| Alcohol Amnestic Disorder | 3 | 1994 | 3 | 0.120 |
Why?
|
| Dendritic Spines | 1 | 2014 | 4 | 0.120 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2013 | 8 | 0.120 |
Why?
|
| Cell Membrane | 3 | 2019 | 96 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 126 | 0.120 |
Why?
|
| Quinoxalines | 2 | 2007 | 13 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2015 | 289 | 0.110 |
Why?
|
| Gene Expression | 3 | 2007 | 338 | 0.110 |
Why?
|
| DNA | 2 | 2003 | 226 | 0.110 |
Why?
|
| Locomotion | 1 | 2013 | 31 | 0.110 |
Why?
|
| Alcoholic Intoxication | 1 | 2013 | 28 | 0.110 |
Why?
|
| Afferent Pathways | 1 | 2012 | 23 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2001 | 833 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2012 | 23 | 0.100 |
Why?
|
| Protein Transport | 1 | 2012 | 74 | 0.100 |
Why?
|
| Adolescent | 1 | 2020 | 3539 | 0.100 |
Why?
|
| Oxazines | 1 | 2011 | 1 | 0.100 |
Why?
|
| Benzopyrans | 1 | 2011 | 6 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 19 | 0.090 |
Why?
|
| Food Additives | 1 | 2010 | 1 | 0.090 |
Why?
|
| Dopamine Agonists | 1 | 2011 | 28 | 0.090 |
Why?
|
| Dopamine Antagonists | 1 | 2011 | 22 | 0.090 |
Why?
|
| Sweetening Agents | 1 | 2010 | 7 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 48 | 0.090 |
Why?
|
| Indans | 1 | 2011 | 31 | 0.090 |
Why?
|
| Piperazines | 1 | 2011 | 54 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2010 | 32 | 0.090 |
Why?
|
| Food Preferences | 1 | 2010 | 36 | 0.090 |
Why?
|
| Kinetics | 3 | 2003 | 209 | 0.090 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2001 | 5 | 0.080 |
Why?
|
| Alanine | 1 | 2009 | 27 | 0.080 |
Why?
|
| Pertussis Toxin | 3 | 1998 | 17 | 0.080 |
Why?
|
| Ion Channels | 2 | 2001 | 24 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 75 | 0.080 |
Why?
|
| Tetrodotoxin | 1 | 2007 | 11 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 26 | 0.070 |
Why?
|
| Thiamine Deficiency | 4 | 1995 | 4 | 0.070 |
Why?
|
| Flunitrazepam | 1 | 2007 | 3 | 0.070 |
Why?
|
| Transfection | 2 | 1998 | 191 | 0.070 |
Why?
|
| GABA Modulators | 1 | 2007 | 8 | 0.070 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 12 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2007 | 19 | 0.070 |
Why?
|
| Environment | 1 | 2007 | 54 | 0.070 |
Why?
|
| Affect | 1 | 2007 | 69 | 0.070 |
Why?
|
| Geniculate Bodies | 1 | 2006 | 23 | 0.070 |
Why?
|
| Cell Size | 1 | 2006 | 38 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2006 | 29 | 0.070 |
Why?
|
| Binding Sites | 2 | 2004 | 130 | 0.070 |
Why?
|
| Calcium Channels, T-Type | 1 | 2006 | 29 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 726 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2018 | 406 | 0.060 |
Why?
|
| beta-Alanine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Thiamine | 2 | 1995 | 4 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 12 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 15 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 43 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 34 | 0.060 |
Why?
|
| Calcium | 2 | 2003 | 307 | 0.060 |
Why?
|
| Dogs | 1 | 2004 | 120 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2003 | 1 | 0.060 |
Why?
|
| DNA Probes | 1 | 2003 | 19 | 0.060 |
Why?
|
| Parthenogenesis | 1 | 2003 | 7 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2003 | 18 | 0.060 |
Why?
|
| Benzodiazepines | 1 | 2003 | 9 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 2003 | 12 | 0.050 |
Why?
|
| Midazolam | 1 | 2003 | 10 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 81 | 0.050 |
Why?
|
| Synaptic Membranes | 1 | 2002 | 3 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2002 | 114 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 1188 | 0.050 |
Why?
|
| Cadmium | 1 | 2002 | 7 | 0.050 |
Why?
|
| Mercury | 1 | 2002 | 6 | 0.050 |
Why?
|
| Telencephalon | 1 | 2002 | 3 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 41 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2001 | 3 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2001 | 12 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2002 | 40 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 64 | 0.050 |
Why?
|
| 2-Chloroadenosine | 1 | 2001 | 1 | 0.050 |
Why?
|
| omega-Agatoxin IVA | 1 | 2001 | 1 | 0.050 |
Why?
|
| Ethylmaleimide | 1 | 2001 | 6 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2001 | 120 | 0.050 |
Why?
|
| Adenosine | 1 | 2001 | 59 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 322 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 8 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 173 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 114 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2002 | 31 | 0.040 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1998 | 3 | 0.040 |
Why?
|
| Anesthetics | 1 | 1997 | 18 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 57 | 0.040 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 1997 | 33 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 247 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2018 | 117 | 0.040 |
Why?
|
| Clathrin | 1 | 2016 | 3 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Endosomes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 31 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2016 | 20 | 0.030 |
Why?
|
| Analgesics | 1 | 1997 | 109 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 35 | 0.030 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 4 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 46 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 39 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 229 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1995 | 7 | 0.030 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1995 | 45 | 0.030 |
Why?
|
| Microdialysis | 1 | 2015 | 34 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2015 | 25 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1995 | 17 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 946 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 94 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 582 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1995 | 60 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 97 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 232 | 0.030 |
Why?
|
| Bicuculline | 1 | 2013 | 10 | 0.030 |
Why?
|
| Biophysics | 1 | 2013 | 11 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 3 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 18 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1993 | 24 | 0.030 |
Why?
|
| Brain Injuries | 1 | 1994 | 93 | 0.030 |
Why?
|
| Hela Cells | 1 | 1993 | 79 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1993 | 48 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2002 | 10 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 2 | 2002 | 17 | 0.030 |
Why?
|
| Base Sequence | 1 | 1993 | 252 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 285 | 0.030 |
Why?
|
| Reference Values | 1 | 1993 | 246 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 359 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2002 | 61 | 0.030 |
Why?
|
| Thiamine Pyrophosphate | 3 | 1995 | 4 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2009 | 5 | 0.020 |
Why?
|
| Receptors, GABA-B | 1 | 2009 | 13 | 0.020 |
Why?
|
| Volatilization | 1 | 2007 | 5 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 25 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2007 | 25 | 0.020 |
Why?
|
| Reverse Transcription | 1 | 2006 | 1 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 142 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 81 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2003 | 5 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2003 | 4 | 0.010 |
Why?
|
| Blastocyst | 1 | 2003 | 11 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 12 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 11 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 69 | 0.010 |
Why?
|
| Cerebellum | 1 | 2002 | 26 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 18 | 0.010 |
Why?
|
| Microchemistry | 1 | 2002 | 5 | 0.010 |
Why?
|
| Parvalbumins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2002 | 32 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2002 | 7 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 38 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2002 | 28 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 51 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 133 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 153 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 284 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 469 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 997 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1997 | 12 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1995 | 1 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1995 | 10 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 1995 | 9 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1995 | 19 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1995 | 7 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 30 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1995 | 79 | 0.010 |
Why?
|
| Chromosomes | 1 | 1995 | 9 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 63 | 0.010 |
Why?
|
| Mutation | 1 | 1997 | 489 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1995 | 135 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1995 | 57 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1995 | 111 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 61 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1993 | 80 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1993 | 147 | 0.010 |
Why?
|
| Risk Factors | 1 | 1993 | 3876 | 0.000 |
Why?
|